Physician profile
Keneth Brandon Strenge
NPI 1386865426
$2,573,517.49
in general payments reported to CMS, 2019-2025
50 companies · $533K in 2025
The $533K reported for 2025 was more than what 99% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $177K · 2020: $147K · 2021: $340K · 2022: $476K · 2023: $366K · 2024: $534K · 2025: $533K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $245K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $24K · Food and Beverage: $19K · Travel and Lodging: $19K · Entertainment: $4,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,120,155.73 |
| Consulting Fee | $245,331.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $24,375.00 |
| Food and Beverage | $19,242.16 |
| Travel and Lodging | $18,956.33 |
| Entertainment | $4,814.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $633,507.55 | 2019-2025 | Other - Miscellaneous, Amp, Solus Alif |
| Nuvasive, INC. | $482,170.80 | 2020-2023 | Cohere, Simplify Cervical Artificial Disc, Acp |
| Corelink, LLC | $361,740.44 | 2019-2023 | |
| Globus Medical, INC. | $337,627.11 | 2019-2025 | Cohere, Cohere, Coroent |
| Zavation Medical Products, LLC | $150,005.65 | 2023-2025 | |
| Stryker Corporation | $101,326.67 | 2019-2025 | Ravine Lateral Access System, Lateral Access Spinal System |
| Centinel Spine, LLC | $89,318.19 | 2019-2025 | Prodisc C Vivo, Prodisc C Sk |
| Intrinsic Therapeutics | $69,311.01 | 2020-2025 | Barricaid Acd (Annular Closure Device) |
| Expanding Innovations, INC. | $65,391.87 | 2021-2025 | X-Pac |
| Ossdsign USA Incorporated | $42,687.98 | 2022-2025 | Ossdsign Catalyst |
| Spineology INC. | $36,966.04 | 2019-2022 | |
| Restor3d, INC. | $30,059.18 | 2020-2025 | |
| Aurora Spine, INC. | $22,450.00 | 2024-2025 | Aurora Spine, Zip |
| Surgalign Spine Technologies, INC. | $21,116.35 | 2019-2021 | |
| 4web, INC. | $19,880.00 | 2019-2023 | Spine Truss System |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $17,311.58 | 2023-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Vb Spine LLC | $16,730.54 | 2025 | Niagara Lateral Access System |
| Spineart USA INC | $12,192.60 | 2021-2025 | Perla Tl |
| Prosidyan, INC | $11,574.88 | 2019-2021 | |
| Medtronic, INC. | $10,933.28 | 2021-2024 | Anteralign Spinal System With Titan Nanolock Surface Technology, Catalyft Pl Expandable Interbody System, Intellis Adaptivestim |
| Depuy Synthes Products, INC. | $10,423.59 | 2022 | |
| Providence Medical Technology, INC. | $7,910.18 | 2019-2025 | |
| Curiteva, INC. | $4,796.15 | 2024 | |
| Atlas Spine, INC. | $4,267.66 | 2020 | |
| Elevation Spine, INC. | $3,223.58 | 2023-2024 | |
| Surgentec | $1,853.34 | 2025 | Tilink, Ion |
| Si-Bone, INC. | $1,722.50 | 2022-2024 | |
| Bioventus LLC | $1,623.50 | 2021-2025 | None |
| Highridge Medical LLC | $1,148.61 | 2025 | Mobi-C Plug & Fit US |
| Spinesmith Holdings, LLC | $934.81 | 2019 | |
| Kuros Biosciences USA, INC | $561.42 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $517.08 | 2019 | |
| Davol INC. | $435.88 | 2024-2025 | Avitene Ultrafoam |
| Depuy Synthes Sales INC. | $276.39 | 2019-2021 | |
| Boston Scientific Corporation | $248.57 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Integrity Implants INC. Dba Accelus | $209.45 | 2024 | |
| Alafair Biosciences, INC. | $200.80 | 2022-2025 | Versawrap |
| Orthofix Medical, INC. | $157.71 | 2019-2025 | Physio-Stim |
| Amgen INC. | $156.52 | 2019-2024 | Evenity, Prolia |
| Arteriocyte Medical Systems, INC. | $129.03 | 2023 | Magellan |
| Biocomposites INC | $126.63 | 2025 | Stimulan |
| Acuity Surgical Devices, LLC | $100.26 | 2022 | |
| Cerapedics INC. | $77.60 | 2021 | |
| Ethicon US, LLC | $38.50 | 2021 | |
| Horizon Therapeutics Plc | $36.97 | 2019 | |
| Pfizer INC. | $20.51 | 2021 | |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$486,688.14 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$241,462.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keneth Strenge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.